A hepatic hemangioma is a liver mass made of widened (dilated) blood vessels. It is not cancerous.
Liver hemangioma; Hemangioma of the liver; Cavernous hepatic hemangioma; Infantile hemangioendothelioma; Multinodular hepatic hemangiomatosis
A hepatic hemangioma is the most common type of liver mass that is not caused by cancer. It may be a birth defect.
Hepatic hemangiomas can occur at any time. They are most common in people in their 30s to 50s. Women get these masses more often than men. The masses are often bigger in size.
Babies may develop a type of hepatic hemangioma called benign infantile hemangioendothelioma. This is also known as multinodular hepatic hemangiomatosis. This is a rare, noncancerous tumor that has been linked to high rates of heart failure and death in infants. Infants are most often diagnosed by the time they are 6 months old.
Some hemangiomas may cause bleeding or interfere with organ function. Most do not produce symptoms. In rare cases, the hemangioma may rupture.
Most of these tumors are treated only if there is ongoing pain.
Treatment for infantile hemangioendothelioma depends on the child's growth and development. The following treatments may be needed:
Surgery can cure a tumor in an infant if it is only in one lobe of the liver. This can be done even if the child has heart failure.
Pregnancy and estrogen-based medicines can cause these tumors to grow.
The tumor may rupture in rare cases.
Di Bisceglie AM, Befeler AS. Hepatic tumors and cysts. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 10th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 96.
Mendes BC, Tollefson MM, Bower TC. Pediatric vascular tumors. In: Sidawy AN, Perler BA, eds. Rutherford's Vascular Surgery and Endovascular Therapy. 9th ed. Philadelphia, PA: Elsevier; 2019:chap 188.
Soares KC, Pawlik TM. The management of liver hemangioma. In: Cameron JL, Cameron AM, eds. Current Surgical Therapy. 12th ed. Philadelphia, PA: Elsevier; 2017:349-354.